The U.S. Food and Drug Administration is voluntarily recalling a blood pressure medication after an impurity classified as a cancer-causing chemical was found.
According to the FDA, Losartan Potassium-Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension.
The recall includes 100 milligram/25 milligram tablets with the lot number JB8912.
CNN reports, the drug is being recalled because the active ingredient has tested positive for N-Nitrosodiethylamine, or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a lubricant additive, according to the National Institutes of Health.
For more information or to report an issue with the medication click here.